ctrl K

Price Alert

Citius Pharmaceuticals In... (CTXR)

NASDAQ: CTXR · Real-Time Price · USD

1.33

0.10 (8.13%)

At close: Aug 22, 2025, 3:59 PM

1.36

2.26%

After-hours: Aug 22, 2025, 07:36 PM EDT

Citius Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is October - September.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Cash & Equivalents	3.25M	26.48M	41.71M	70.07M
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	29.18M
Other Long-Term Assets	38.06K	38.06K	39.97M	38.06K
Receivables	n/a	n/a	n/a	n/a
Inventory	8.27M	n/a	n/a	n/a
Other Current Assets	n/a	n/a	n/a	n/a
Total Current Assets	14.22M	34.37M	44.56M	72.81M
Property-Plant & Equipment	246.25K	455.86K	650.17K	829.85K
Goodwill & Intangibles	102.15M	68.75M	68.75M	68.75M
Total Long-Term Assets	102.43M	69.24M	69.44M	69.61M
Total Assets	116.65M	103.61M	114M	142.43M
Account Payables	4.93M	2.93M	1.17M	1.28M
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	196.99K	177.24K
Other Current Liabilities	n/a	476.3K	1.57M	1.73M
Total Current Liabilities	35.81M	5.78M	4.53M	3.98M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	6.74M	6.4M	6.04M	5.66M
Total Liabilities	42.55M	12.18M	10.57M	9.65M
Total Debt	262.87K	481.25K	678.23K	855.47K
Common Stock	7.25K	158.86K	146.21K	145.98K
Retained Earnings	-201.37M	-162.23M	-129.69M	-96.05M
Comprehensive Income	n/a	n/a	n/a	n/a
Shareholders Equity	70.08M	90.83M	102.83M	132.18M
Total Investments	n/a	n/a	n/a	29.18M